The natural history and treatment outcome of blast phase BCR-ABL− myeloproliferative neoplasms
CS Tam, RM Nussenzveig, U Popat… - Blood, The Journal …, 2008 - ashpublications.org
We analyzed the outcomes of 74 patients diagnosed with BCR-ABL− myeloproliferative
neoplasms in blast phase receiving induction chemotherapy (55%), low-intensity therapy …
neoplasms in blast phase receiving induction chemotherapy (55%), low-intensity therapy …
Activating mutations in human acute megakaryoblastic leukemia
S Malinge, C Ragu, V Della-Valle… - Blood, The Journal …, 2008 - ashpublications.org
Oncogenic activation of tyrosine kinase signaling pathway is recurrent in human leukemia.
To gain insight into the oncogenic process leading to acute megakaryoblastic leukemia …
To gain insight into the oncogenic process leading to acute megakaryoblastic leukemia …
Choosing between stem cell therapy and drugs in myelofibrosis
Optimal clinical management of patients with primary myelofibrosis and post-essential
thrombocythemia/polycythemia vera myelofibrosis is a challenge, given the typically …
thrombocythemia/polycythemia vera myelofibrosis is a challenge, given the typically …
A dynamic prognostic model to predict survival in post–polycythemia vera myelofibrosis
F Passamonti, E Rumi, M Caramella… - Blood, The Journal …, 2008 - ashpublications.org
Post–polycythemia vera myelofibrosis (post-PV MF) is a late evolution of PV. In 647 patients
with PV, we found that leukocytosis leukocyte count>(15× 109/L) at diagnosis is a risk factor …
with PV, we found that leukocytosis leukocyte count>(15× 109/L) at diagnosis is a risk factor …
Risk factors for leukemic transformation in patients with primary myelofibrosis
J Huang, CY Li, RA Mesa, W Wu… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND. Previous prognostic studies in primary myelofibrosis have focused on risk
factors for overall survival and have resulted in the establishment of several prognostic …
factors for overall survival and have resulted in the establishment of several prognostic …
Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)
JT Reilly - Leukemia, 2008 - nature.com
The frequency of cytogenetic abnormalities in the Philadelphia-negative myeloproliferative
neoplasms (MPNs) varies from approximately 30% in primary myelofibrosis (PMF) to less …
neoplasms (MPNs) varies from approximately 30% in primary myelofibrosis (PMF) to less …
Familial chronic myeloproliferative disorders: the state of the art
E Rumi - Hematological oncology, 2008 - Wiley Online Library
Familial chronic myeloproliferative disorders are defined when in the same pedigree at least
two relatives have a chronic myeloproliferative disorder (CMD) as polycythemia vera (PV) …
two relatives have a chronic myeloproliferative disorder (CMD) as polycythemia vera (PV) …
Primary central nervous system leukemia presenting with an isolated oculomotor palsy
N Çelebisoy, FE Bayam, S Çağırgan… - Journal of Clinical …, 2008 - Elsevier
Primary central nervous system leukemia presenting with an isolated oculomotor palsy -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …
PRCA with myelofibrosis: an unusual case report
R Kar, M Mahapatra, HP Pati - Indian Journal of Hematology and Blood …, 2008 - Springer
The association of PRCA and myelofibrosis is very rare with only two such cases reported in
the literature. Leukemic transformation in myelofibrosis is known but the progression of …
the literature. Leukemic transformation in myelofibrosis is known but the progression of …
Acute Leukemia Arising from the Myeloproliferative Disorders: Challenge and Opportunity
RA Mesa - Clinical Leukemia, 2008 - Elsevier
The classical myeloproliferative disorders (MPDs) of essential thrombocythemia,
polycythemia vera, and primary myelofibrosis have an increasing predisposition to transform …
polycythemia vera, and primary myelofibrosis have an increasing predisposition to transform …